{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T04:41:05Z","timestamp":1784176865674,"version":"3.55.0"},"reference-count":59,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["nrjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nutrition Research"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1016\/j.nutres.2015.02.006","type":"journal-article","created":{"date-parts":[[2015,2,26]],"date-time":"2015-02-26T19:46:53Z","timestamp":1424980013000},"page":"489-495","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Cyclic supplementation of 5-MTHF is effective for the correction of hyperhomocysteinemia"],"prefix":"10.1016","volume":"35","author":[{"given":"Pasquale","family":"Ambrosino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Lupoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Di Minno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Assunta","family":"Nardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emiliana","family":"Marrone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Lupoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Scaravilli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Mitidieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Tufano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo Nicola Dario","family":"Di Minno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nutres.2015.02.006_bb0005","doi-asserted-by":"crossref","first-page":"535","DOI":"10.2165\/11532990-000000000-00000","article-title":"Folic Acid and L-5-Methyltetrahydrofolate. Comparison of Clinical Pharmacokinetics and Pharmacodynamics","volume":"49","author":"Pietrzik","year":"2010","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.nutres.2015.02.006_bb0010","doi-asserted-by":"crossref","first-page":"480","DOI":"10.3325\/cmj.2013.54.480","article-title":"Clinical significance of determining plasma homocysteine: case\u2013control study on arterial and venous thrombotic patients","volume":"54","author":"Vuckovic","year":"2013","journal-title":"Croat Med J"},{"key":"10.1016\/j.nutres.2015.02.006_bb0015","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1160\/TH09-06-0393","article-title":"Homocysteine and arterial thrombosis: Challenge and opportunity","volume":"103","author":"Di Minno","year":"2010","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.nutres.2015.02.006_bb0020","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1093\/ajcn\/82.4.806","article-title":"Dose-dependent effects of folic acid on blood concentrations of homocysteine: a meta-analysis of the randomized trials","volume":"82","year":"2005","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.nutres.2015.02.006_bb0025","doi-asserted-by":"crossref","first-page":"1276S","DOI":"10.1093\/jn\/126.suppl_4.1276S","article-title":"Vitamins as homocysteine lowering agents","volume":"126","author":"Brattstrom","year":"1996","journal-title":"J Nutr"},{"key":"10.1016\/j.nutres.2015.02.006_bb0030","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1055\/s-0037-1613864","article-title":"The role of vit. B12 in fasting hyperhomocysteinemia and its interaction with the homozygous C677T mutation of the methylenetetrahydrofolate reductase (MTHFR) gene. A case\u2013control study of patients with early-onset thrombotic events","volume":"83","author":"D\u2019Angelo","year":"2000","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.nutres.2015.02.006_bb0035","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1161\/01.ATV.17.6.1157","article-title":"The effects of folic acid supplementation on plasma homocysteine are modulated by multivitamin use and methylenetetrahydrofolate reductase genotypes","volume":"17","author":"Malinow","year":"1997","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.nutres.2015.02.006_bb0040","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1093\/ajcn\/75.2.275","article-title":"5,10-Methylenetetrahydrofolate reductase genotype determines the plasma homocysteinelowering effect of supplementation with 5-methyltetrahydrofolate or folic acid in healthy young women","volume":"75","author":"Fohr","year":"2002","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.nutres.2015.02.006_bb0045","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1046\/j.1365-2362.2002.01055.x","article-title":"Effect of low doses of 5-methyltetrahydrofolate and folic acid on plasma homocysteine in healthy subjects with or without the 677C- > T polymorphism of methylenetetrahydrofolate reductase","volume":"32","author":"Litynski","year":"2002","journal-title":"Eur J Clin Investig"},{"key":"10.1016\/j.nutres.2015.02.006_bb0050","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1001\/jama.1992.03490070059042","article-title":"A prospective study of plasma homocyst(e)ine and risk of myocardial infarction in US physicians","volume":"268","author":"Stampfer","year":"1992","journal-title":"JAMA"},{"key":"10.1016\/j.nutres.2015.02.006_bb0055","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1093\/ije\/24.4.704","article-title":"Serum total homocysteine and coronary heart disease","volume":"24","author":"Arnesen","year":"1995","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.nutres.2015.02.006_bb0060","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1001\/archinte.158.8.862","article-title":"Homocysteine and ischemic heart disease: results of a prospective study with implications regarding prevention","volume":"158","author":"Wald","year":"1998","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.nutres.2015.02.006_bb0065","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1001\/archinte.159.1.38","article-title":"Homocysteine and short-term risk of myocardial infarction and stroke in the elderly: the Rotterdam study","volume":"159","author":"Bots","year":"1999","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.nutres.2015.02.006_bb0070","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1016\/S0140-6736(95)92407-8","article-title":"Prospective study of serum total homocysteine concentration and risk of stroke in middle-aged British men","volume":"346","author":"Perry","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.nutres.2015.02.006_bb0075","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1056\/NEJM199603213341203","article-title":"Hyperhomocysteinemia as a risk factor for deep-vein thrombosis","volume":"334","author":"den Heijer","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nutres.2015.02.006_bb0080","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.3892\/mmr.2012.1086","article-title":"C677T methylenetetrahydrofolate reductase gene polymorphism as a risk factor involved in venous thromboembolism: a population-based case\u2013control study","volume":"6","author":"Yin","year":"2012","journal-title":"Mol Med Rep"},{"key":"10.1016\/j.nutres.2015.02.006_bb0085","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1001\/jama.1995.03530130055028","article-title":"A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes","volume":"274","author":"Boushey","year":"1995","journal-title":"JAMA"},{"key":"10.1016\/j.nutres.2015.02.006_bb0090","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1001\/jama.1997.03540460039030","article-title":"Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project","volume":"277","author":"Graham","year":"1997","journal-title":"JAMA"},{"key":"10.1016\/j.nutres.2015.02.006_bb0095","first-page":"135","article-title":"Thrombophilia and adverse pregnancy outcome","volume":"42","author":"Mousa","year":"2001","journal-title":"Croat Med J"},{"key":"10.1016\/j.nutres.2015.02.006_bb0100","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/j.1365-2796.1995.tb01190.x","article-title":"Plasma homocysteine in acute myocardial infarcation: homocysteine-lowering effect of folic acid","volume":"237","author":"Landgren","year":"1995","journal-title":"J Intern Med"},{"key":"10.1016\/j.nutres.2015.02.006_bb0105","first-page":"3","article-title":"Plasma homocysteine response to folate intervention in young women","volume":"164","author":"Cuskelly","year":"1995","journal-title":"Ir J Med Sci"},{"key":"10.1016\/j.nutres.2015.02.006_bb0110","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1093\/ajcn\/69.1.99","article-title":"Low-dose folic acid supplementation decreases plasma homocysteine: a randomized trial","volume":"69","author":"Brouwer","year":"1999","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.nutres.2015.02.006_bb0115","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1093\/ajcn\/77.5.1318","article-title":"Folic acid and plasma homocysteine reduction in older adults: a dose-finding study","volume":"77","author":"van Oort","year":"2003","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.nutres.2015.02.006_bb0120","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1007\/BF00180030","article-title":"Hyperhomocysteinemia and the response to vitamin supplementation","volume":"71","author":"Ubbink","year":"1993","journal-title":"Clin Investig"},{"key":"10.1016\/j.nutres.2015.02.006_bb0125","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1093\/jn\/124.10.1927","article-title":"Vitamin requirements for the treatment of hyperhomocysteinemia in humans","volume":"124","author":"Ubbink","year":"1994","journal-title":"J Nutr"},{"key":"10.1016\/j.nutres.2015.02.006_bb0130","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1161\/01.ATV.18.3.356","article-title":"Vitamin supplementation reduces blood homocysteine levels: a controlled trial in patients with venous thrombosis and healthy volunteers","volume":"18","author":"den Heijer","year":"1998","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.nutres.2015.02.006_bb0135","doi-asserted-by":"crossref","first-page":"2829","DOI":"10.1161\/01.CIR.101.24.2829","article-title":"Controlled comparison of L-5-methyltetrahydrofolate versus folic acid for the treatment of hyperhomocysteinemia in hemodialysis patients","volume":"101","author":"Bostom","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.nutres.2015.02.006_bb0140","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1093\/ajcn\/77.3.658","article-title":"Comparison of the effect of low-dose supplementation with L-5-methyltetrahydrofolate or folic acid on plasma homocysteine: a randomized placebo-controlled study","volume":"77","author":"Venn","year":"2003","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.nutres.2015.02.006_bb0145","first-page":"516","article-title":"A long-term study of the absorption of large oral doses of folic acid","volume":"11","author":"Zettner","year":"1981","journal-title":"Ann Clin Lab Sci"},{"key":"10.1016\/j.nutres.2015.02.006_bb0150","doi-asserted-by":"crossref","first-page":"163","DOI":"10.3177\/jnsv.33.163","article-title":"Effect of long-term supplementation of folate on folate status in plasma and erythrocytes","volume":"33","author":"Heseker","year":"1987","journal-title":"J Nutr Sci Vitaminol (Tokyo)"},{"key":"10.1016\/j.nutres.2015.02.006_bb0155","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1093\/ajcn\/88.2.448","article-title":"Folate status and homocysteine response to folic acid doses and withdrawal among young Chinese women in a large-scale randomized double-blind trial","volume":"88","author":"Hao","year":"2008","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.nutres.2015.02.006_bb0160","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1111\/j.1365-2141.2005.05732.x","article-title":"Reduced in vivo oxidative stress following 5-methyl-tetrahydrofolate supplementation in patients with early-onset thrombosis and 677TT methylenetetrahydrofolate reductase genotype","volume":"131","author":"Coppola","year":"2005","journal-title":"Br J Haematol"},{"key":"10.1016\/j.nutres.2015.02.006_bb0165","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.autneu.2013.10.006","article-title":"Moderate hyperhomocysteinemia provokes dysfunction of cardiovascular autonomic system and liver oxidative stress in rats","volume":"180","author":"Mendes","year":"2014","journal-title":"Auton Neurosci"},{"key":"10.1016\/j.nutres.2015.02.006_bb0170","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.thromres.2010.12.005","article-title":"Abnormally high prevalence of major components of the metabolic syndrome in subjects with early-onset idiopathic venous thromboembolism","volume":"127","author":"Di Minno","year":"2011","journal-title":"Thromb Res"},{"key":"10.1016\/j.nutres.2015.02.006_bb0175","doi-asserted-by":"crossref","first-page":"e43","DOI":"10.1016\/j.thromres.2011.05.017","article-title":"Genotype-independent in vivo oxidative stress following a methionine loading test: maximal platelet activation in subjects with early-onset thrombosis","volume":"128","author":"Di Minno","year":"2011","journal-title":"Thromb Res"},{"key":"10.1016\/j.nutres.2015.02.006_bb0180","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.jnutbio.2006.11.010","article-title":"Red blood cell folate vitamer distribution in healthy subjects is determined by the methylenetetrahydrofolate reductase C677T polymorphism and by the total folate status","volume":"18","author":"Smulders","year":"2007","journal-title":"J Nutr Biochem"},{"key":"10.1016\/j.nutres.2015.02.006_bb0185","doi-asserted-by":"crossref","first-page":"761","DOI":"10.7326\/0003-4819-146-11-200706050-00157","article-title":"Homocysteine-lowering therapy and risk for venous thromboembolism: a randomized trial","volume":"146","author":"Ray","year":"2007","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.nutres.2015.02.006_bb0190","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1182\/blood-2006-04-014654","article-title":"Homocysteine lowering by B vitamins and the secondary prevention of deep vein thrombosis and pulmonary embolism: A randomized, placebo-controlled, double-blind trial","volume":"109","author":"den Heijer","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.nutres.2015.02.006_bb0195","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/0026-0495(85)90082-4","article-title":"Folic acid responsive postmenopausal homocysteinemia","volume":"34","author":"Brattstr\u00f6m","year":"1985","journal-title":"Metabolism"},{"key":"10.1016\/j.nutres.2015.02.006_bb0200","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1093\/ajcn\/83.4.842","article-title":"[6S]-5-Methyltetrahydrofolate is at least as effective as folic acid in preventing a decline in blood folate concentrations during lactation","volume":"83","author":"Houghton","year":"2006","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.nutres.2015.02.006_bb0205","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1093\/ajcn\/79.3.473","article-title":"Supplementation with [6S]-5- methyltetrahydrofolate or folic acid equally reduces plasma total homocysteine concentrations in healthy women","volume":"79","author":"Lamers","year":"2004","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.nutres.2015.02.006_bb0210","doi-asserted-by":"crossref","first-page":"15812","DOI":"10.1073\/pnas.1309049110","article-title":"Hydrogen sulphide pathway contributes to the enhanced human platelet aggregation in hyperhomocysteinemia","volume":"110","author":"d'Emmanuele di Villa","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.nutres.2015.02.006_bb0215","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1136\/bmj.316.7135.894","article-title":"Lowering blood homocysteine with folic acid based supplements: meta-analysis of randomised trials","volume":"316","year":"1998","journal-title":"Br Med J"},{"key":"10.1016\/j.nutres.2015.02.006_bb0220","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1001\/jama.291.5.565","article-title":"Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death. The Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial","volume":"291","author":"Toole","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.nutres.2015.02.006_bb0225","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1056\/NEJMoa055227","article-title":"Homocysteine lowering and cardiovascular events after acute myocardial infarction","volume":"354","author":"B\u00f8naa","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nutres.2015.02.006_bb0230","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1056\/NEJMoa060900","article-title":"Homocysteine lowering with folic acid and B vitamins in vascular disease","volume":"354","author":"The Heart Outcomes Prevention Evaluation (HOPE) 2 Investigators","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nutres.2015.02.006_bb0235","doi-asserted-by":"crossref","first-page":"2720","DOI":"10.1001\/jama.296.22.2720","article-title":"Effect of folic acid supplementation on risk of cardiovascular diseases. A meta-analysis of randomized controlled trials","volume":"296","author":"Bazzano","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.nutres.2015.02.006_bb0240","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1001\/jama.298.10.1163","article-title":"Effect of homocysteine lowering on mortality and vascular disease in advanced chronic kidney disease and end-stage renal disease: a randomized controlled trial","volume":"298","author":"Jamison","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.nutres.2015.02.006_bb0245","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1001\/jama.299.17.2027","article-title":"Effect of folic acid and B vitamins on risk of cardiovascular events and total mortality among women at high rsk for cardiovascular disease: a randomized trial","volume":"299","author":"Albert","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.nutres.2015.02.006_bb0250","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1001\/jama.300.7.795","article-title":"Mortality and cardiovascular events in patients treated with homocysteine- lowering B vitamins after coronary angiography: a randomized controlled trial","volume":"300","author":"Ebbing","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.nutres.2015.02.006_bb0255","first-page":"CD006612","article-title":"Homocysteine lowering interventions for preventing cardiovascular events (Review)","author":"Marti-Carvajal","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.nutres.2015.02.006_bb0260","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1161\/CIRCULATIONAHA.105.570846","article-title":"Improvement in stroke mortality in Canada and the United States, 1990 to 2002","volume":"113","author":"Yang","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.nutres.2015.02.006_bb0265","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.ejim.2012.07.004","article-title":"Efficacy of folic acid supplementation in cardiovascular disease prevention: an updated meta-analysis of randomized controlled trials","volume":"23","author":"Yang","year":"2012","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.nutres.2015.02.006_bb0270","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1161\/01.RES.86.11.1129","article-title":"Folic acid reverts dysfunction of endothelial nitric oxid synthase","volume":"86","author":"Stroes","year":"2000","journal-title":"Circ Res"},{"key":"10.1016\/j.nutres.2015.02.006_bb0275","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1161\/hq0102.102190","article-title":"Folate and cardiovascular disease","volume":"22","author":"Verhaar","year":"2002","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.nutres.2015.02.006_bb0280","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1079\/BJN2001323","article-title":"Re-evaluation of the metabolism of oral doses of racemic carbon isomers of formyltetrahydrofolate in human subjects","volume":"85","author":"Baggott","year":"2001","journal-title":"Br J Nutr"},{"key":"10.1016\/j.nutres.2015.02.006_bb0285","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.thromres.2011.10.006","article-title":"Urinary excretion of iPF(2\u03b1)-III predicts the risk of future thrombotic events. A 10-year follow-up","volume":"129","author":"Di Minno","year":"2012","journal-title":"Thromb Res"},{"key":"10.1016\/j.nutres.2015.02.006_bb0290","series-title":"Vitamin requirements for the reduction of homocysteine blood levels in healthy young women","author":"Dierkes","year":"1995"},{"key":"10.1016\/j.nutres.2015.02.006_bb0295","first-page":"172A","article-title":"B-vitamin supplementation lowers homocysteine levels in heart disease","volume":"42","author":"Saltzman","year":"1994","journal-title":"Clin Res"}],"container-title":["Nutrition Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0271531715000421?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0271531715000421?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,21]],"date-time":"2019-08-21T05:34:59Z","timestamp":1566365699000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0271531715000421"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6]]},"references-count":59,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["S0271531715000421"],"URL":"https:\/\/doi.org\/10.1016\/j.nutres.2015.02.006","relation":{},"ISSN":["0271-5317"],"issn-type":[{"value":"0271-5317","type":"print"}],"subject":[],"published":{"date-parts":[[2015,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cyclic supplementation of 5-MTHF is effective for the correction of hyperhomocysteinemia","name":"articletitle","label":"Article Title"},{"value":"Nutrition Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nutres.2015.02.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}